³í¹®) Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
¿¬¼¼¾Ïº´¿ø Æó¾Ï¼¾ÅÍ ¾Èº´Ã¶·ÀÌÁöÇö·È«¹ÎÈñ ±³¼ö ¿¬±¸ÆÀ